Actinium is the real deal in curing cancer without the need to attack healthy cells. But this company had been manipulated for quite some times now. I think this will be the beginning of a major push up real real soon.
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells safely and...
Actinium Pharmaceuticals, Inc. is a biopharmaceutical company. It is focused on developing Antibody Radiation-Conjugates, which combine the targeting ability of antibodies with the cell killing ability of radiation. Its product pipeline includes Iomab-B, Actimab-A, and Actimab-M. The company was founded in 1993 and is headquartered in New York, NY.
Actinium Pharmaceuticals, Inc. is a biopharmaceutical company. It is focused on developing Antibody Radiation-Conjugates, which combine the targeting ability of antibodies with the cell killing ability of radiation. Its product pipeline includes Iomab-B, Actimab-A, and Actimab-M. The company was founded in 1993 and is headquartered in New York, NY.
Disclaimer: thank you for taking your time to look at my idea please understand that I didn't publish it to influence your decision to invest your money and void myself of any responsibility towards your investments.
Note: I am simply trying to increase the coverage that the company may or may not have by publishing an optimistic guess I don't know anything about...
ATNM is showing some slow climb in pennies that may be trying to develop into something towards 20% and 80% returns just ahead.
While risky looking there are some indications for a retest toward 0.30 and then fill gap to 0.45.
Took starting positions at 0.24 with support of two week old uptrend line just below.
Prices have just recently moved out from three...
1000 shares. Going long. above its 200 day ema. Good volume in this stock. earnings are steady. Inverse head and shoulders pattern indicating the stock has bottomed. the target price is $4.
As for the structure of the wave, a 0.5x fractal. Within a fractal with a decreasing triple wave structure. Although the theory contradicts the rising wave axis, but since it can not be mirrored, we did not take into account the opposite sign. But back to the triple waveform. Resistance color is an extension of an ATR axis. The bottom and top levels of the...
